with initiation Certainty of evidence For patients starting any ULT, we strongly recommend allopurinol over all other ULT as the preferred first-line agent for all patients, including in those with CKD stage >3. Moderate We strongly recommend a xanthine oxidase inhibitor over probenecid for those with CKD stage >3. For allopurinol and febuxostat, we strongly recommend starting at a low dose with subsequent dose titration to target over starting at a higher dose (e.g., <100 mg/day [and lower in